Atlas Trials

An Implant for Hearing Loss Due to Removal of Neurofibromatosis 2 Tumors

Clinical trial NCT00030043 · COMPLETED

Trial details

NCT number
NCT00030043
Sponsor
FDA Office of Orphan Products Development
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neurofibromatosis 2
Start date
2001-09-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.